Largest health care biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 health care biotech companies ranked by total debt, at HUF 18.6T, ahead of Gilead Sciences (HUF 8.49T) and Biogen (HUF 2.14T). Figures as of 20 Nov 2026, 12:00 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenHUF 18.6T
Median
HUF 200.9B
Combined market value
HUF 282.12T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
Health Care
Biotech
HUF
Clear filters
Largest health care biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareHUF 18.6THUF 80.84THUF 149,448.93 1.14% down 30% up United States
2Gilead SciencesGILD · Health CareHUF 8.49THUF 70.35THUF 56,715.12 1.45% down 31% up United States
3BiogenBIIB · Health CareHUF 2.14THUF 12.44THUF 84,165.06 1.70% down 41% up United States
4Halozyme TherapeuticsHALO · Health CareHUF 729.7BHUF 3.61THUF 31,686.63 2.88% down 32% up United States
5QiagenQGEN · Health CareHUF 563.4BHUF 3.49THUF 16,902.49 0.14% up 6% up Netherlands
6ModernaMRNA · Health CareHUF 200.9BHUF 27.47THUF 67,885.82 1.29% up 740% up United States
7RepligenRGEN · Health CareHUF 184.7BHUF 3.71THUF 57,995.67 1.38% down 5% up United States
8Bio-TechneTECH · Health CareHUF 68.1BHUF 3.89THUF 24,759.44 0.07% down 18% up United States
9Adaptive BiotechnologiesADPT · Health CareHUF 44.7BHUF 1.55THUF 9,552.99 1.44% down 51% up United States
10Scholar Rock HoldingSRRK · Health CareHUF 34BHUF 2.09THUF 17,154.51 4.94% up 25% up United States
11CG OncologyCGON · Health CareHUF 1BHUF 2.49THUF 27,892.68 2.38% up 93% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 340.6 HUF). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which health care biotech companies rank first by total debt?

Amgen (HUF 18.6T), Gilead Sciences (HUF 8.49T) and Biogen (HUF 2.14T) are the top three of the 11 health care biotech companies ranked by total debt as of 20 Nov 2026, 12:00 UTC.

How many health care biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these health care biotech companies worth together?

The 11 health care biotech companies ranked by total debt have a combined market value of HUF 282.12T as of 20 Nov 2026, 12:00 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest health care biotech companies by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.